COVID-19 Severity in Patients With Apical Periodontitis: A Case Control Study

OBJECTIVES

Apical periodontitis (AP) has been associated with systemic inflammatory biomarkers that have also been associated with COVID-19 severity. This study was designed to test the hypothesis that the presence of apical periodontitis could be associated with increased risk of COVID-19 complications.

METHODS

A case control study (N = 949) was performed using the medical and dental records of patients diagnosed with COVID-19 in the State of Qatar between March 2020 and February 2021. Cases comprised COVID-19 patients (n = 63) who experienced complications (death, intensive care unit admissions, mechanical ventilation), and controls were COVID-19 patients (n = 886) who recovered without such complications. The presence of periapical apical periodontitis was assessed on the radiographic records taken prior to COVID-19 infection. Associations between apical periodontitis and COVID 19 complications were analysed using logistic regression models adjusted for demographic and medical factors. Blood biomarkers were assessed in both groups and compared using the Kruskal-Wallis test.

RESULTS

COVID-19 complications were found to be associated with the presence of apical periodontitis (adjusted odds ratio = 2.72; 95% CI, 1.30-5.68; P = .008). Blood analyses revealed that COVID-19 patients with apical periodontitis had higher levels of white blood cells and haemoglobin A1c than the patients without apical periodontitis.

CONCLUSIONS

The presence of apical periodontitis could be associated with increased risk of COVID-19 complications.

A Cone-Beam Computed Tomography (CBCT) Study of Root Anatomy, Canal Morphology and Bilateral Symmetry of Permanent Maxillary Premolar Teeth Among the Qatari Subpopulation

Objectives:

The study aims to evaluate the root anatomy, canal morphology, and symmetry of maxillary premolars teeth in a Qatari subpopulation using cone-beam computed tomography (CBCT).

Materials and Methods:

544 CBCT images of Qatari patients were analyzed by two endodontists. Tooth position, number of roots, canal configuration, and number of canals per root were investigated. A chi-square test was used to evaluate the association between gender and the number of roots. The interexaminer and intraexaminer were performed and documented.

Results:

The most common root anatomy and canal morphology observed in maxillary first premolars (MFP) were two roots (70.6%) with a single canal per root, while in maxillary second premolars (MSP), there was one root (84.3%) with a single canal (83%).

Type I Vertucci morphology was predominated in all roots of two-rooted MFP (97%), three-rooted MFP (100%), single-rooted MSP (42%), and two-rooted MSP (100%). The Chi-square test showed an association between gender and number of roots in both MFP and MSP, with a higher number of roots seen in men(P<0.05).

A symmetrical pattern was observed in the number of roots and canals in both maxillary premolars. But the symmetry for the type of canal configuration is higher in MFP (78%) than MSP (54%).

Conclusion:

In the Qatari subpopulation, most MFP had two roots with a predominance of type I Vertucci, while MSP had one root with type I. Contralateral MSP showed more diversity in canal configuration that should be considered during root canal treatment. CBCT is an effective diagnostic tool to investigate root anatomy and canal morphology.

Association between periodontitis and severity of COVID-19 infection: A case-control study

AIM

COVID-19 is associated with an exacerbated inflammatory response that can result in fatal outcomes. Systemic inflammation is also a main characteristic of periodontitis. Therefore, we investigated the association of periodontitis with COVID-19 complications.

MATERIALS AND METHODS

A case-control study was performed using the national electronic health records of the State of Qatar between February and July 2020. Cases were defined as patients who suffered COVID-19 complications (death, ICU admissions or assisted ventilation), and controls were COVID-19 patients discharged without major complications. Periodontal conditions were assessed using dental radiographs from the same database. Associations between periodontitis and COVID 19 complications were analysed using logistic regression models adjusted for demographic, medical and behaviour factors.

RESULTS

In total, 568 patients were included. After adjusting for potential confounders, periodontitis was associated with COVID-19 complication including death (OR = 8.81, 95% CI 1.00-77.7), ICU admission (OR = 3.54, 95% CI 1.39-9.05) and need for assisted ventilation (OR = 4.57, 95% CI 1.19-17.4). Similarly, blood levels of white blood cells, D-dimer and C Reactive Protein were significantly higher in COVID-19 patients with periodontitis.

CONCLUSION

Periodontitis was associated with higher risk of ICU admission, need for assisted ventilation and death of COVID-19 patients, and with increased blood levels of biomarkers linked to worse disease outcomes.

Natural radioactivity and radiological hazard assessment of Egyptian oil ashes

Oil fly and boiler ash samples were collected from the four major Egyptian power plants in order to determine their natural radioactivity. Secular equilibrium between (238)U and (232)Th and their decay products is significantly disturbed in oil ash samples. The (226)Ra/(238)U ratios were between 440 and 1993 with an average value of 801, indicating that the concentrations of daughters (226)Ra were very high compared to the parent (238)U in the oil ash samples. While, the average ratios for (210)Pb/(226)Ra in most samples were 1.19 ± 0.05, indicating a secular equilibrium in the (226)Ra-(210)Pb sub series. The natural radioactivity due to (238)U and (232)Th was found to be negligible. While the activity concentrations of (226)Ra ranged from 3205 to 12,320 Bq kg(-1) with an average value of 9284 Bq kg(-1), (210)Pb ranged from 5960 to 13,930 Bq kg(-1) with an average value of 11,513 Bq kg(-1). The results are compared with the reported data from other countries. The average value of radium equivalent activity was 9308 ± 2729 Bq kg(-1), while the external and internal hazard indexes were found to be 25 ± 7 and 50 ± 15, respectively. All the studied radiological parameters were higher than the recommended limit by the IAEA in all ash samples.

Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study

BACKGROUND

The eradication rate of Helicobacter pylori with standard treatments are decreasing worldwide.

AIM

To determine whether adding simvastatin as adjuvant to triple regimen in patients with H. pylori infection will improve the eradication rate.

METHODS

We conducted a double-blind, placebo-controlled, randomised clinical trial comparing a 7-day, triple eradication regimen consisting of two antibiotics (clarithromycin 500 mg and amoxicillin 1 g, all twice per day) plus a proton pump inhibitor (omeprazole 20 mg twice daily) supplemented with simvastatin 20 mg (CAO + S) or a comparable placebo (CAO + P). Both the simvastatin and the placebo were taken orally twice daily for 1 week in 113 patients with H. pylori infection. The presence of H. pylori was determined by positive rapid urease test and histology. Eradication was confirmed by ¹³C-urea breath test at least 1 month after treatment. Adverse effects were assessed by questionnaire.

RESULTS

A total of 113 patients underwent randomisation. Intention-to-treat analysis (ITT; n = 113) eradication rates were: CAO + S (86%; 95% CI: 78-92%), CAO + P (69%; 95% CI: 64-74%). Per protocol analysis (PP; n = 108) eradication rates were: CAO + S (91%; 95% CI: 84-94%), CAO + P (72%; 95% CI: 65-78%). Eradication rates were higher with CAO + S than CAO + P in PP and ITT (P = 0.03, P = 0.04 respectively). No differences were demonstrated between the two groups concerning compliance or adverse effects.

CONCLUSION

In this randomised clinical trial simvastatin as adjuvant to standard therapy improves significantly the H. pylori eradication rate.

[Two cases of Crimean-Congo haemorrhagic fever (CCHF) in two tourists in Senegal in 2004]

Two cases of Crimean-Congo haemorrhagic fever (CCHF) occurred in two French tourists during their visit in Senegal in November 2004. Febrile and hemorrhagic syndrome with ulorrhagia, petechiae, haematemesis, haematomas associated with biological signs of disseminated intramuscular coagulation were observed. For the first case who had a medical evacuation to France before diagnosis, Crimean-Congo virus infection was revealed by laboratory tests performed by the National Reference Center for Hemorrhagic Fevers (NRCHF, Institut Pasteur, Lyon) and secondly by the Centre de Référence OMS sur la Recherche des Arbovirus et des virus des Fièvres Hémorragiques (CRORA) in the Dakar Pasteur Institute (DPI). The second case diagnosed by the CRORA died after clinical deterioration with liver failure and severe haemorrhages. Healthcare workers and family members who had contact with tissue or blood from patients were followed up after the putative exposure either in France or in Senegal.